ES2103222B1 - Derivados de tioalquiltiocarbacefalosporina. - Google Patents

Derivados de tioalquiltiocarbacefalosporina.

Info

Publication number
ES2103222B1
ES2103222B1 ES09302051A ES9302051A ES2103222B1 ES 2103222 B1 ES2103222 B1 ES 2103222B1 ES 09302051 A ES09302051 A ES 09302051A ES 9302051 A ES9302051 A ES 9302051A ES 2103222 B1 ES2103222 B1 ES 2103222B1
Authority
ES
Spain
Prior art keywords
derivatives
acil
formula
thioalkyltiocarbacefalosporin
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES09302051A
Other languages
English (en)
Other versions
ES2103222A1 (es
Inventor
Tadatoshi Kubota
Masaharu Kume
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of ES2103222A1 publication Critical patent/ES2103222A1/es
Application granted granted Critical
Publication of ES2103222B1 publication Critical patent/ES2103222B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

DERIVADOS DE TIOALQUILTIOCARBACEFALOSPORINA UN COMPUESTO DE FORMULA I: FORMULA DONDE ACIL ES ACILO C1-12; HET ES UN GRUPO HETEROAROMATICO MONOCICLICO OPCIONALMENTE SUSTITUIDO QUE CONTIENE UNO O MAS HETEROATOMOS; R1 ES UN ENLACE SENCILLO O ALQUILENO C1-4; R2 ES UN ALQUILENO C1-4 LINEAL O RAMIFICADO; E Y ES UN ATOMO DE HIDROGENO O UN GRUPO METOXI, O UNA DE SUS SALES FARMACEUTICAMENTE ACEPTABLES, O UNO DE SUS DERIVADOS AMINO-, CARBOXI- Y/O HIDROXI-PROTEGIDOS, QUE TIENEN UNA POTENTE ACTIVIDAD ANTIBIOTICA.
ES09302051A 1992-09-30 1993-09-28 Derivados de tioalquiltiocarbacefalosporina. Expired - Lifetime ES2103222B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26147892A JP3238209B2 (ja) 1992-09-30 1992-09-30 チオメチルチオカルバセファロスポリン誘導体

Publications (2)

Publication Number Publication Date
ES2103222A1 ES2103222A1 (es) 1997-09-01
ES2103222B1 true ES2103222B1 (es) 1998-06-16

Family

ID=17362465

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09302051A Expired - Lifetime ES2103222B1 (es) 1992-09-30 1993-09-28 Derivados de tioalquiltiocarbacefalosporina.

Country Status (8)

Country Link
US (1) US5362724A (es)
JP (1) JP3238209B2 (es)
BE (1) BE1007544A3 (es)
CH (1) CH687205A5 (es)
ES (1) ES2103222B1 (es)
FR (1) FR2696179B1 (es)
GB (1) GB2271564B (es)
IT (1) IT1271421B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0133937B1 (ko) * 1989-02-22 1998-04-18 말키 예후다 상이 박힌 비누 제조방법
US5565445A (en) * 1995-02-22 1996-10-15 Merck & Co., Inc. 3-thioheteroaryl 1-carba-1-dethiacephalosporin compounds, compositions and methods of use
MX2010004407A (es) * 2007-10-25 2010-07-28 Achaogen Inc Antibioticos de carbacefem beta-lactama.
WO2010030811A2 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. CARBACEPHEM β-LACTAM ANTIBIOTICS
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA766941B (en) * 1975-11-21 1978-06-28 Merck & Co Inc 3-(substituted thio)cephalosporins,derivatives and nuclear analogues thereof
JPS60174787A (ja) * 1984-02-21 1985-09-09 Kyowa Hakko Kogyo Co Ltd ３位置換カルバセフエム化合物
JPH0653739B2 (ja) * 1984-11-15 1994-07-20 協和醗酵工業株式会社 ３位置換カルバセフエム化合物
DE3803169A1 (de) * 1988-02-03 1989-08-17 Bayer Ag Ss-lactam-antibiotika, verfahren zu ihrer herstellung und ihre verwendung als und in arzneimitteln
IE65926B1 (en) * 1990-07-19 1995-11-29 Shionogi & Co Thioalkylthio cephalosporin derivatives
US5077287A (en) * 1991-01-18 1991-12-31 Eli Lilly And Company 3-thiazolylthio carbacephem antibacterial agents

Also Published As

Publication number Publication date
GB2271564B (en) 1996-03-06
GB9319338D0 (en) 1993-11-03
GB2271564A (en) 1994-04-20
JPH06107660A (ja) 1994-04-19
ITMI932073A1 (it) 1995-03-29
CH687205A5 (fr) 1996-10-15
JP3238209B2 (ja) 2001-12-10
IT1271421B (it) 1997-05-28
FR2696179A1 (fr) 1994-04-01
US5362724A (en) 1994-11-08
FR2696179B1 (fr) 1996-01-05
BE1007544A3 (fr) 1995-08-01
ES2103222A1 (es) 1997-09-01
ITMI932073A0 (it) 1993-09-29

Similar Documents

Publication Publication Date Title
ES2093445T3 (es) Inyeccion y estuche de inyeccion que contiene omeprazol y sus analogos.
MX9303100A (es) Nuevos derivados de n-aril- y n-heteroaril-urea como inhibidores de acil-coenzima a: colesterol acil transferasa (acat).
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
ATE207906T1 (de) Phenylimidazolidine und deren verwendung als anti-androgene mittel
DK0513387T3 (da) Thiazolderivater som inhibitorer af aktivt oxygen
ATA244992A (de) Stabilisiertes pharmazeutisches mittel, enthaltend einen hmg-coa-reduktase-inhibitor wirkstoff
TW342310B (en) Non-systemic external dermal control of parasites
TR199903098T2 (xx) �midozil-siklik asetaller
PT1204322E (pt) Fungicidas
ATE275134T1 (de) 4-oxo-1,4-dihydro-3-chinolincarboxamide als antivirale mittel
DE3776433D1 (de) Antimikrobielle mittel.
DK1300401T3 (da) Thiazolderivater til anvendelse som antiinflammatoriske midler
BR9607560A (pt) Composições cométicas anidras contendo agentes dermatologicamente ativo
TR199902283T2 (xx) �kame edilmi� izokuinolin t�revleri ve bunlar�n antikonvulsant olarak kullan�m�.
DE69812634D1 (de) Metalloproteinase-inhibitoren
AR026421A1 (es) Compuesto de imidazol como inhibidores de la fosfodiesterasa vii
DE60036889D1 (de) Arzneimittelträger
ES2103222B1 (es) Derivados de tioalquiltiocarbacefalosporina.
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
NO911999L (no) Anvendelse av substituerte beta-hydroksyetylaminer som potente hemmestoffer til exoenzymer i sopp.
DK0642506T3 (da) Heterocyclisk disubstituerede sulfonaminocarbonylforbindelser
EA199900834A1 (ru) Антивирусные средства
TR199800813T2 (xx) Nitrik oksit sintaz�n�n �nleyicileri olarak amidin, isot�re t�revleri.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
SV1998000088A (es) Compuestos farmaceuticos

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970901

Kind code of ref document: A1

Effective date: 19970901